AUBREY HESTIR: Open Payments
NPI 1700538345 · GREENWOOD, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$765 in 31 payments from 12 companies in 2025. Trend: 2023 $1,120 · 2024 $1,401 · 2025 $765
Food & beverage: $765
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 5 | $260 |
| Edwards Lifesciences Corporation | 3 | $80 |
| Novartis Pharmaceuticals Corporation | 4 | $80 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $78 |
| Abbott Laboratories | 3 | $57 |
| Philips North America LLC | 2 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| Boston Scientific Corporation | 1 | $31 |
| Novo Nordisk Inc | 1 | $27 |
Products named: SAPIEN 3 Ultra RESILIA, LifeVest, LEQVIO, Ambulatory Monitoring & Diagnostics Undivided, FARXIGA, WATCHMAN FLX, Wegovy, GALLANT.
Industry payments across SC — which companies pay providers there.
